The transforming growth factor-β/SMAD signaling pathway is present and functional in human mesangial cells

Kidney International

Volumn 56, Issue 4, 1999, Pages 1354-1365

  Poncelet, Anne Christine ^a   De Caestecker, Mark P ^b   William Schnaper, H ^b  

^a Pediatrics W 140   (United States)

^b NONE

Author keywords

Extracellular matrix; Glomerulosclerosis; Luciferase; Serine phosphoacceptor sites; Type I collagen

Indexed keywords

CELL CULTURE; CONFERENCE PAPER; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0032824798     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00680.x     Document Type: Conference Paper

References (56)

1. SCHNAPER HW. Focal segmental glomerulosclerosis, in Immunologie Renal Disease, edited by NEILSON EG, COUSER WG, New York, Lippincott-Raven, 1997, pp 1003-1026
2. YAMAMOTO T, NOBLE NA, COHEN AH, NAST CC, HISHIDA A, GOLD LI, BORDER WA. Expression of transforming growth factor-β isoforms in human glomcrular disease. Kidney Int 49:461-469, 1996
3. YAMAMOTO T, NAKAMURA T, NOBLE NA, RUOSLAHTI E, BORDER WA. Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
4. YOSHIOKA K,nTAKEMURA T, MURAKAMI K, OKADA M, HINO S, MIYAMOTO H, MAKI S. Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 68:154-163, 1993
5. NIEMIR ZI, STEIN H, NORONHA IL, KRUGER C, ANDRASSY K, RITZ E, WALDHERR R. PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis. Kidney Int 48:1530-1541, 1995
6. TOMOOKA S, BORDER WA, MARSHALL BC, NOBLE NA. Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int 42:1462-1469, 1992
7. OKUDA S, LANGUINO LR, RUOSLAHTI E, BORDER WA. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomcrulonephritis. Possible role in expansion of extracellular matrix. J Clin Invest 86:453-462, 1990
8. MANSCH GM, WAGNER C, BURGER A, DONC W, STAEHLER G, SIOEK M. Matrix protein synthesis by glomerular mesangial cells in culture. Effects of transforming growth factor β (TGFβ) and plateletderived growth factor (PDGF) on fibronectin and collagen type IV mRNA. J Cell Physiol 163:451-457, 1995
9. McKAY NG, KHONG TF, HAITES NE, POWER DA. The effect of transforming growth factor β1 on mesangial cell fibronectin synthesis. Increased incorporation into the extracellular matrix and reduced pi but no effect on alternative splicing. Exp Mol Pathol 59:211-224, 1993
10. PONCELET A-C, SCHNAPER HW. Rcgulatio'n of mesangial cell collagen turnover by transforming growth factor-β1. Am J Physiol 275(3 Pt 2):F458-F466, 1998
11. NEGRETE H, STUDER RK, CRAVEN PA, DERUBERTIS FR. Role for transforming growth factor-β in thromboxane-induced increases in mesangial cell fibronectin synthesis. Diabetes 44:335-339, 1995
12. OHTA K, KIM S, HAMAGUCHI A, YUKIMURA T, MIURA K, TAKAORI K, IWAO H. Role of angiotensin II in extracellular matrix and transforming growth factor-β1 expression in hypertensive rats. Enr J Pliarmacol 269:115-119, 1994
13. GRANDE JP. Role of transforming growth factor-β in tissue injury and repair. Exp Biol Med 214:27-40, 1997
14. Josso N, DI CLEMENTE N. Serine/threonine kinase receptors and ligands. Ctirr Opin Genet Dev 7:371-377, 1997
15. SEKELSKY JJ, NEWFELD SJLAR, CHARTOFF EF, WMG. Genetic characterization and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosopliila inelaiwgaster. Genetics 139:1347-1358, 1995
16. RAFTERY LA, TWOMBLY V, WHARTON K, GELBART WM. Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila. Genetics 139:241-254, 1995
17. SAVAGE C, DAS P, FINELLI A, TOWNSEND SR, SUN C-Y, BAIRD SE, PADGETT RW. Caenorlwbditis elegans genes sma-2, sina-3 and sina-4 define a conserved family of transforming growth factor β pathway components. Proc Natl Acad Sci USA 93:790-794, 1996
18. HELDIN C-H, MIYAZONO K, TEN DUKE P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471, 1997
19. KRETSCHMAR M, MASSAGUE J. SMADs. Mediators and regulators of TGF-β signaling. Curr Opin Genet Dev 8:103-111, 1998
20. Liu F, POUPONNOT C, MASSAGUE J. Dual role of the Smad4/DPC4 tumor suppressor in TGFβ-inducible transcriptional complexes. Genes Dev 11:3157-3167, 1997
21. CHEN X, WEISBERG E, FRIDMACHER V, WATANABE M, NACO G, WHITMAN M. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389:85-89, 1997
22. DENNLER S, ITOH S, VIVIEN D, TEN DUKE P, HUET S, GAUTHIER J-M. Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17:3091-3100, 1998
23. JONK LJC, ITOH S, HELDIN C-H, TEN DUKE P, KRUUER W. Identifi-cation and functional characterization of a Smad binding element (SBE) in the JiinB promoter that acts as a transforming growth factor-β, activin, and bone morphogenetic protein-inducible enhancer, J Biol Chem 273:21145-21152, 1998
24. YINCLINC JM, DATTO MB, WONO C, FREDERICK JP, LIBERATI NT, WANG X-F. Tumor suppressor Smad4 is a transforming growth factor-β-inducible DNA binding protein. Mol Cell Biol 17:7019-7028, 1997
25. NAKAO A, AFRAKHTE M, MOREN A, NAKAYAMA T, CHRISTIAN JL, HEUCHEL R, ITOH S, KAWABATA M, HELDIN N-E, HELDIN C-H, TENDUKE P. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling. Nature 389:631-635, 1997
26. IMAMURA T, TAKASE M, NISHIHARA A, OEDA E, HANAI J-I, KAWABATA M, MIYAZONO K. Smado inhibits signaling by the TGFβ superfamily. Nature 389:622-626, 1997
27. HAYASHI H, ABDOLLAH S, QUI Y, CAI J, XU Y-Y, GRINNELL BW, RICHARDSON MA, TOPPER JN, GIMBRONE MA JR, WRANA JL, FALB D. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89:1165-1173,1997
28. HATA A, LAGNA G, MASSAGUE J, HEMMATI-BRIVANLOU A. Smado inhibits BMP/Smadl signaling by specifically competing with the Smad4 tumor suppressor. Genes Dcv 12:186-197, 1998
29. SCHNAPER HW, KOPP JB, HUBCHAK SC, PONCELET A-C, STETLER-STEVENSON WG, BRUGGEMAN LA, KLOTMAN PE, KLEINMAN HK. Increased expression of extracellular matrix proteins and decreased expression of matrix proteases after serial passage of glomerular mesangial cells. J Cell Sci 109:2521-2528, 1996
30. CHOMCZYNSKI P, SACCHI N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
31. EPPERT K, SCHERER SW, OZCELIK H, PIRONE R, HOODLESS P, KIM H, Tsui LC, BAPAT B, GALLINGER S, ANDRULIS IL, THOMSEN GH, WRANA JL, ATTISANO L. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543-552, 1996
32. ZHANG Y, FENG X-H, Wu R-Y, DERYNCK R. Receptor-associated Mad homologues synergize as effectors of TGF-β responses. Nature 383:168-172, 1996
33. DE CAESTECKER MP, HEMMATI P, LARISCH-BLOCH S, AJMERA R, ROBERTS AB, LECHLEIDER RJ. Characterization of functional domains within Smad4/DPC4. J Biol Cliem 272:13690-13696, 1997
34. WRANA JL, ATTISANO L, CARCAMO J, ZENTELLA A, DOODY J, LAIHO M, WANG X-F, MASSAGUE J. TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71:1003-1014, 1992
35. Liu X, SUN Y, CONSTANTINESCU SN, KARA E, WEINBERG RA, LODISH HF. Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acail Sci USA 94:10669-10674, 1997
36. BOAST S, Su M-W, RAMIREZ F, SANCHEZ M, AWEDIMENTO EV. Functional analysis of cis-acting DNA sequences controlling transcription of the human type I collagen genes. J Biol Chem 265:13351-13356, 1990
37. NORDEEN SK. Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6:454-158, 1988
38. INAGAKI Y, TRUTER S, RAMIREZ F. Transforming growth factor-β stimulates α2(1) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J Biol Chem 269:14828-14834, 1994
39. TAKASE M, IMAMURA T, SAMPATH TK, TAKEDA K, ICHIJO H, MIYAZONO K, KAWABATA M. Induction of Smado mRNA by bone morphogenetic proteins. Biocliem Biopliys Res Commun 244:26-29, 1998
40. AFRAKTE M, MOREN A, JOSSAN S, ITOH S, SAMPATH K, WESTERMARK B, HELDIN C-H, HELDIN N-E, TEN DUKE P. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members. Biochem Biophys Res Commun 249:505-511, 1998
41. CHEN Y-G, LIU, F, MASSAGUE J. Mechanism of TGFβ receptor inhibition by FKBP12. EMBO J 16:3866-3876, 1997
42. WANG T, Li B-Y, DANIELSON PD, SHAH PC, ROCKWELL S, LECHLEIDER RJ, MARTIN J, MANGNAROT, DONAHOE PK:The immunophi-lin FKBP12 functions as a common inhibitor of the TGFβ family type I receptors. Cell 86:435-444, 1996
43. HAHN SA, SCHUTTE M, HOQUE ATMS, MOSKALUK CA, DA COSTA LT, ROZENBLUM E, WEISNSTEIN CL, FISHER Y, YEO CJ, HRUBAN RH. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353, 1996
44. WALDRIP WR, BIKOFF EK, HOODLESS PA, WRANA JL, ROBERTSON EJ. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell 92:797-808, 1998
45. ZHAO J, LEE M, SMITH S, WARBURTON D. Abrogation of Smad3 and Smad2 or of Smad4 gene expression positively regulates murine embryonic lung branching morphogenesis in culture. Dev Biol 194:182-195, 1998
46. Usui T, TAKASE M, KAJI Y, SUZUKI K, ISHIDA K, TSURU T, MIYATA K, KAWABATA M, YAMASHITA H. Extracellular matrix production regulation by TGF-β in corneal endothelial cells. Invest Ophtlialmol Vis Sci 39:1981-1989, 1998
47. CHEN S-J, YUAN W, LEVENSON AS, MORI Y, TROJANOVVSKA M, VARGA J. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β. Involvement of Smad3. J Invest Dermatol 112:49-57, 1999
48. Wu R-Y, ZHANG Y, FENG X-H, DERYNK R. Heterodimeric and homodimeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol Cell Biol 17:2521-2528, 1997
49. VlNDEVOGHEL L, KON A, LECHLEIDER RJ, UlTTO J, ROBERTS AB, MAUVIEL A. Smad-dependent transcriptional activation of human type VII collagen gene (COL7A1) promoter by transforming growth factor-β. J Biol Chem 273:13053-13057, 1998
50. ZAWEL L, LE DAI J, BUCKHAULTS P, Ziiou S, KINZLER KW, VOLGELSTEIN B, KERN SE. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1:611-617, 1998
51. JANKNECHT R, WELLS NJ, HUNTER T. TGF-β-stimulated cooperation of Smad proteins with the coactivators CBP/p300. Genes Dev 12:2114-2119, 1998
52. FENG XH, ZHANG Y, Wu R-Y, DERYNCK R. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation. Genes Dev 12:2153-2163, 1998
53. TOPPER JN, DICHIARA MR, BROWN JD, WILLIAMS AJ, FALB D, COLLINS T, GiMBRONE MA JR. CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor β transcriptional responses in endothelial cells. Proc Natl Acad Sci USA 95:9506-9511, 1998
54. ZHANG Y, FENG X-H, DERYNCK R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature 394:909-913, 1998
55. CHUNG K-Y, AGARWAL A, Uirro J, MAUVIEL A. An AP-1 binding sequence is essential for regulation of the human α2(I) collagen (COL1A2) promoter activity by transforming growth factor-β. J Biol Chem 271:3272-3278, 1996
56. GREENWEL P, INAGAKI Y, HU W, WALSH M, RAMIREZ F. Spl is required for the early response of α2(I) collagen to transforming growth factor-β1. J Biol Chem 272:19738-19745, 1997